OBJECTIVES: Men with clinically detected localized prostate cancer treated without curative intent are at risk of complications from local tumor growth. We investigated rates of local progression and need for local therapy among such men. METHODS: Men diagnosed with prostate cancer during 1990-1996 were identified from cancer registries throughout the United Kingdom. Inclusion criteria were age 6 mo after cancer diagnosis. RESULTS: The study included 2333 men with median follow-up of 85 mo (range: 6-174). Diagnosis was by TURP in 1255 men (54%), needle biopsy in 1039 (45%), and unspecified in 39 (2%). Only 29% were treated with hormonal therapy within 6 mo of diagnosis. Local progression occurred in 335 men, including 212 undergoing TURP. F...
PURPOSE: Contemporary treatment strategies for localized prostate cancer (PCa) have been evolved ove...
Background:Men with screen-detected prostate cancer can choose to undergo immediate curative treatme...
TO DETERMINE THE NEED FORtreatment of localized pros-tate cancer, patients and phy-sicians must unde...
This study by Miller et al. retrospectively evaluates 71,602 men who were identified from Surveillan...
Objectives To determine whether local treatment of primary prostate cancer gives palliative benefit ...
OBJECTIVE: To assess the patterns of care for low-risk localized prostate cancer. Management of this...
Purpose: Active surveillance to manage prostate cancer provides an alternative to immediate treatmen...
Context: The appropriate therapy for men with clinically localized prostate cancer is uncertain. A r...
The majority of prostate cancers continue to be clinically diagnosed after the tumor has spread beyo...
Background: There are limited prognostic data for locally advanced prostate cancer PCa to guide in t...
Background: Little information is available on the long-term outcomes of patients with localised pro...
In 2011, 11,428 men were diagnosed with prostate cancer in the Netherlands and 2,500 men died from t...
Prostate cancer is the most frequently diagnosed male cancer in the world. Like all cancers, prostat...
: The incidence of prostate cancer is rising worldwide, caused mainly by demographic factors, partic...
BackgroundMaintaining men on active surveillance for prostate cancer can be challenging. Although mo...
PURPOSE: Contemporary treatment strategies for localized prostate cancer (PCa) have been evolved ove...
Background:Men with screen-detected prostate cancer can choose to undergo immediate curative treatme...
TO DETERMINE THE NEED FORtreatment of localized pros-tate cancer, patients and phy-sicians must unde...
This study by Miller et al. retrospectively evaluates 71,602 men who were identified from Surveillan...
Objectives To determine whether local treatment of primary prostate cancer gives palliative benefit ...
OBJECTIVE: To assess the patterns of care for low-risk localized prostate cancer. Management of this...
Purpose: Active surveillance to manage prostate cancer provides an alternative to immediate treatmen...
Context: The appropriate therapy for men with clinically localized prostate cancer is uncertain. A r...
The majority of prostate cancers continue to be clinically diagnosed after the tumor has spread beyo...
Background: There are limited prognostic data for locally advanced prostate cancer PCa to guide in t...
Background: Little information is available on the long-term outcomes of patients with localised pro...
In 2011, 11,428 men were diagnosed with prostate cancer in the Netherlands and 2,500 men died from t...
Prostate cancer is the most frequently diagnosed male cancer in the world. Like all cancers, prostat...
: The incidence of prostate cancer is rising worldwide, caused mainly by demographic factors, partic...
BackgroundMaintaining men on active surveillance for prostate cancer can be challenging. Although mo...
PURPOSE: Contemporary treatment strategies for localized prostate cancer (PCa) have been evolved ove...
Background:Men with screen-detected prostate cancer can choose to undergo immediate curative treatme...
TO DETERMINE THE NEED FORtreatment of localized pros-tate cancer, patients and phy-sicians must unde...